These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26589000)

  • 1. Association of chitotriosidase enzyme activity and genotype with the risk of nephropathy in type 2 diabetes.
    Elmonem MA; Amin HS; El-Essawy RA; Mehaney DA; Nabil M; Kamel LN; Farid IM
    Clin Biochem; 2016 Apr; 49(6):444-448. PubMed ID: 26589000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between tumour necrosis factor-alpha G-308A polymorphism and risk of nephropathy in obese Chinese type 2 diabetic patients.
    Wang Y; Ng MC; So WY; Ma R; Ko GT; Tong PC; Chan JC
    Nephrol Dial Transplant; 2005 Dec; 20(12):2733-8. PubMed ID: 16141456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NLRP3 expression and urinary HSP72 in relation to biomarkers of inflammation and oxidative stress in diabetic nephropathy patients.
    El-Horany HE; Abd-Ellatif RN; Watany M; Hafez YM; Okda HI
    IUBMB Life; 2017 Aug; 69(8):623-630. PubMed ID: 28631886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of the 174G>C polymorphism of interleukin 6 gene with diabetic nephropathy in patients with type 2 diabetes mellitus.
    Papaoikonomou S; Tentolouris N; Tousoulis D; Papadodiannis D; Miliou A; Papageorgiou N; Hatzis G; Stefanadis C
    J Diabetes Complications; 2013; 27(6):576-9. PubMed ID: 23871133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between apolipoprotein E genetic polymorphism and the development of diabetic nephropathy in type 2 diabetic patients.
    Kwon MK; Rhee SY; Chon S; Oh S; Woo JT; Kim SW; Kim JW; Kim YS; Jeong KH; Lee SH; Lee TW; Ihm CG
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S228-32. PubMed ID: 17624465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in glycosylation of human blood plasma chitotriosidase in patients with type 2 diabetes.
    Żurawska-Płaksej E; Kratz EM; Ferens-Sieczkowska M; Knapik-Kordecka M; Piwowar A
    Glycoconj J; 2016 Feb; 33(1):29-39. PubMed ID: 26494371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitotriosidase is the primary active chitinase in the human lung and is modulated by genotype and smoking habit.
    Seibold MA; Donnelly S; Solon M; Innes A; Woodruff PG; Boot RG; Burchard EG; Fahy JV
    J Allergy Clin Immunol; 2008 Nov; 122(5):944-950.e3. PubMed ID: 18845328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteins from the 18 glycosyl hydrolase family are associated with kidney dysfunction in patients with diabetes type 2.
    Żurawska-Płaksej E; Ługowska A; Hetmańczyk K; Knapik-Kordecka M; Adamiec R; Piwowar A
    Biomarkers; 2015 Feb; 20(1):52-7. PubMed ID: 25519006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Angiotensin converting enzyme (ACE) gene polymorphism in a diabetic cohort and diabetic nephropathy].
    Levinson O; Oren S; Yagil C; Sapojnikov M; Wechsler A; Bloch R; Yagil Y
    Harefuah; 1999 May; 136(10):768-73, 843. PubMed ID: 10955109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of chitotriosidase enzyme activity in nephropathic cystinosis.
    Elmonem MA; Makar SH; van den Heuvel L; Abdelaziz H; Abdelrahman SM; Bossuyt X; Janssen MC; Cornelissen EA; Lefeber DJ; Joosten LA; Nabhan MM; Arcolino FO; Hassan FA; Gaide Chevronnay HP; Soliman NA; Levtchenko E
    Orphanet J Rare Dis; 2014 Nov; 9():155. PubMed ID: 25407738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitotriosidase: A New Inflammatory Marker in Diabetic Complications.
    Di Rosa M; Malaguarnera L
    Pathobiology; 2016; 83(4):211-9. PubMed ID: 27116685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uromodulin gene variant is associated with type 2 diabetic nephropathy.
    Ahluwalia TS; Lindholm E; Groop L; Melander O
    J Hypertens; 2011 Sep; 29(9):1731-4. PubMed ID: 21738052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of specific angiotensin-converting enzyme variants and haplotypes that confer risk and protection against type 2 diabetic nephropathy.
    Ezzidi I; Mtiraoui N; Kacem M; Chaieb M; Mahjoub T; Almawi WY
    Diabetes Metab Res Rev; 2009 Nov; 25(8):717-24. PubMed ID: 19787680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum chitotriosidase enzyme activity is closely related to HbA1c levels and the complications in patients with diabetes mellitus type 2.
    Turan E; Sozmen B; Eltutan M; Sozmen EY
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S503-S506. PubMed ID: 28392356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of LMNA 1908C/T polymorphism with cerebral vascular disease and diabetic nephropathy in Japanese men with type 2 diabetes.
    Liang H; Murase Y; Katuta Y; Asano A; Kobayashi J; Mabuchi H
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):317-22. PubMed ID: 16117820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1.
    Kimura H; Gejyo F; Suzuki Y; Suzuki S; Miyazaki R; Arakawa M
    Kidney Int; 1998 Nov; 54(5):1659-69. PubMed ID: 9844142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The polymorphism of manganese superoxide dismutase is associated with diabetic nephropathy in Japanese type 2 diabetic patients.
    Nomiyama T; Tanaka Y; Piao L; Nagasaka K; Sakai K; Ogihara T; Nakajima K; Watada H; Kawamori R
    J Hum Genet; 2003; 48(3):138-41. PubMed ID: 12624725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor insertion/deletion gene polymorphism in West Indian patients of type 2 diabetes and diabetic nephropathy.
    Dabhi B; Mistry KN; Patel H; Lal S
    Indian J Biochem Biophys; 2015 Apr; 52(2):209-12. PubMed ID: 26118134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphism of the ACE Gene in dialysis patients: overexpression of DD genotype in type 2 diabetic end-stage renal failure patients.
    Park HC; Choi SR; Kim BS; Lee TH; Kang BS; Choi KH; Lee HY; Han DS; Ha SK
    Yonsei Med J; 2005 Dec; 46(6):779-87. PubMed ID: 16385653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of nitric oxide synthase Glu298Asp polymorphism on the development of end-stage renal disease in type 2 diabetic Egyptian patients.
    El-Din Bessa SS; Hamdy SM
    Ren Fail; 2011; 33(9):878-84. PubMed ID: 21854353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.